July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Validating Optos® ultra wide-field imaging against conventional Topcon® imaging
Author Affiliations & Notes
  • Stine Byberg
    Steno Diabetes Center Copenhagen, Gentofte, Denmark
  • Dorte Visitisen
    Steno Diabetes Center Copenhagen, Gentofte, Denmark
  • Morten Haaning Charles
    Aarhus University, Aarhus, Denmark
  • Marianne Valerius
    Steno Diabetes Center Copenhagen, Gentofte, Denmark
  • Ellen Juul
    Steno Diabetes Center Copenhagen, Gentofte, Denmark
  • Marit Eika Jørgensen
    Steno Diabetes Center Copenhagen, Gentofte, Denmark
  • Henrik Lund-Andersen
    Steno Diabetes Center Copenhagen, Gentofte, Denmark
    Dept. of Ophthalmology, Rigshospitalet, Glostrup, Denmark
  • Footnotes
    Commercial Relationships   Stine Byberg, None; Dorte Visitisen, None; Morten Charles, None; Marianne Valerius, None; Ellen Juul, None; Marit Jørgensen, None; Henrik Lund-Andersen, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 1055. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Stine Byberg, Dorte Visitisen, Morten Haaning Charles, Marianne Valerius, Ellen Juul, Marit Eika Jørgensen, Henrik Lund-Andersen; Validating Optos® ultra wide-field imaging against conventional Topcon® imaging. Invest. Ophthalmol. Vis. Sci. 2018;59(9):1055.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Current diabetic retinopathy screening methods are costly, require highly specialized personnel and patient mydriasis. The new Optos® apparatus can be operated by non-specialists and provides ultra wide-field imaging, with 200° views of the retina in a single image. Conventional methods only provide 90° image views of the retina in up to 16 images. We aimed to validate the Optos® imaging against conventional Topcon® imaging for grading retinopathy.

Methods : We conducted a follow-up study of 101 persons with diabetes who participated in the Addition-DK study. Retina fundus photos using both Optos® and Topcon® imaging were taken for both eyes among all participants. All photos were graded by specialist ophthalmologic nurses, using an adaptation of the Early Treatment Diabetic Retinopathy Scale (ETDRS). We constructed frequency tables separately for peripheral- and macular grading. Levels of agreement between the grading of Optos® and Topcon® images were assessed using weighted Kappa statistics, separately for peripheral and macular imaging

Results : Using Optos® imaging, a larger proportion of the peripheral grading was determined “grade 1” or “grade 2”compared with Topcon® (Figure 1). The inter-camera agreement was substantial (0.63 (95%CI: 0.39-0.87)) for macular retinopathy and fair (0.30 (95%CI: 0.16-0.44)) for peripheral retinopathy (both with a P-value<0.001).

Conclusions : The inter-camera agreement was acceptable for macular retinopathy, but only fair for peripheral retinopathy, with the Optos® apparatus finding more microvascular changes in the periphery than the conventional Topcon® apparatus. Whether this has any clinical significance remains to be explored.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

 

Figure 1. Comparison of retinopathy grading using Topcon® and Optos® in the periphery and in the macula

Figure 1. Comparison of retinopathy grading using Topcon® and Optos® in the periphery and in the macula

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×